CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription
Molecular Cell · 2024-12 · 84 (24) · 4808-4823.e13
DOI: 10.1016/j.molcel.2024.11.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024-12. Verfasst von Roberta Cacioppo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK. Hauptthemen laut MEDLINE: RNA Polymerase II, Ubiquitination, Ubiquitin-Protein Ligases, Transcription, Genetic. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Australian Research Council, UK Research and Innovation Medical Research Council.
Abstract (Originalsprache)
Control of RNA polymerase II (RNA Pol II) through ubiquitylation is essential for the DNA-damage response. Here, we reveal a distinct ubiquitylation pathway in human cells, mediated by CRL3ARMC5, that targets excessive and defective RNA Pol II molecules at the initial stages of the transcription cycle. Upon ARMC5 loss, RNA Pol II accumulates in the free pool and in the promoter-proximal zone but is not permitted into elongation. We identify Integrator subunit 8 (INTS8) as a gatekeeper preventing the release of excess RNA Pol II molecules into gene bodies. Combined loss of ARMC5 and INTS8 has detrimental effects on cell growth and results in the uncontrolled release of excessive RNA Pol II complexes into early elongation, many of which are transcriptionally incompetent and fail to reach the ends of genes. These findings uncover CRL3ARMC5 and Integrator as two distinct pathways acting in parallel to monitor the quantity and quality of transcription complexes before they are licensed into elongation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
- EMBL Australia Node in Single Molecule Science, University of New South Wales, Sydney, NSW, Australia; UNSW RNA Institute, University of New South Wales, Sydney, NSW, Australia; Department of Molecular Medicine, School…
- Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK. Electronic address: atv@mrc-lmb.cam.ac.uk.
Förderung
- Medical Research Council
- Australian Research Council
- UK Research and Innovation Medical Research Council
Zitieren
APA
Cacioppo, R., Gillis, A., Shlamovitz, I., Zeller, A., Castiblanco, D., Crisp, A., Haworth, B., Arabiotorre, A., Abyaneh, P., Bao, Y., Sale, J. E., Berry, S., & Tufegdžić Vidaković, A. (2024). CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription. Molecular Cell, 84(24), 4808-4823.e13. https://doi.org/10.1016/j.molcel.2024.11.024
Vancouver
Cacioppo R, Gillis A, Shlamovitz I, Zeller A, Castiblanco D, Crisp A, et al. CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription. Molecular Cell. 2024;84(24):4808-4823.e13. doi:10.1016/j.molcel.2024.11.024
BibTeX
@article{Cacioppo2024,
author = {Cacioppo, Roberta and Gillis, Alexander and Shlamovitz, Iván and Zeller, Andrew and Castiblanco, Daniela and Crisp, Alastair and Haworth, Benjamin and Arabiotorre, Angela and Abyaneh, Pegah and Bao, Yu and Sale, Julian E and Berry, Scott and Tufegdžić Vidaković, Ana},
title = {CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription},
journal = {Molecular Cell},
year = {2024},
volume = {84},
number = {24},
pages = {4808--4823.e13},
doi = {10.1016/j.molcel.2024.11.024}
}
EUVIMED